Psychiatry and Neurology, Neurology · Irvine, CA
NPI
1376835629
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1 Medical Plaza Drive
Irvine, CA, 92697
Phone (949) 824-8816
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
456 services
Medicare patients, 2024
164
Average age 67
Drug cost, 2024
$4.9M
1,053 prescriptions
Company payments, 2025
$69K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Y Sy was code 99215 (office e&m - established), 182 times for 110 patients. In total Michael Y Sy billed 456 services in 15 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 182 | 110 | $115.80 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 178 | 105 | $13.85 | $2,466 |
| 99205 Office E&M - New | Office | 19 | 19 | $123.52 | $2,347 |
| 99215 Office E&M - Established | Facility | 14 | 11 | $96.96 | $1,358 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $154.66 | $2,011 |
By year: 2022 $29K for 288 services; 2023 $28K for 289 services; 2024 $32K for 456 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Y Sy prescribed most often to Medicare patients was Baclofen, with 103 prescriptions and refills. In total Michael Y Sy wrote 1,053 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 103 | 228 | 32 | $4,072 |
| Soliris Eculizumab | 58 | 58 | Under 11 | $1.6M |
| Kesimpta Pen Ofatumumab | 56 | 56 | Under 11 | $460K |
| Gabapentin Generic | 54 | 92 | 18 | $1,172 |
| Copaxone Glatiramer Acetate | 53 | 67 | Under 11 | $384K |
| Glatiramer Acetate Generic | 47 | 47 | Under 11 | $84K |
| Tizanidine Hcl Generic | 46 | 82 | 13 | $588 |
| Enspryng Satralizumab-Mwge | 43 | 43 | Under 11 | $737K |
| Tamsulosin Hcl Generic | 31 | 65 | Under 11 | $141 |
| Levetiracetam Generic | 27 | 49 | Under 11 | $821 |
| Dalfampridine Er Dalfampridine | 26 | 30 | Under 11 | $19K |
| Sodium Chloride 0.9 % Sodium Chloride | 24 | 29 | Under 11 | $72.74 |
| Duloxetine Hcl Generic | 20 | 50 | Under 11 | $1,141 |
| Ibuprofen Generic | 20 | 24 | Under 11 | $175 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 18 | 18 | Under 11 | $225K |
Brand drugs: 346 claims; generic drugs: 707 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Y Sy $69K ($69K in general payments such as food, travel and fees) from 12 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $47K.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 43 | $47K |
| Genentech USA, Inc. ROG.SW | 12 | $8,574 |
| Amgen Inc. AMGN | 15 | $5,882 |
| UCB, Inc. UCB.BR | 1 | $4,400 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $2,843 |
| TG Therapeutics, Inc. TGTX | 6 | $231 |
| Biogen, Inc. BIIB | 1 | $150 |
| Vanda Pharmaceuticals Inc. VNDA | 7 | $137 |
| Genentech, Inc. ROG.SW | 1 | $97.12 |
| Genzyme Corporation SNY | 2 | $41.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.